Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
Patent No. 8,653,090
Issued: February 18, 2014
Inventor: Ford; John P. (Unadilla NY)
A composition and method for the treatment of the side-effects associated with the administration of cancer chemotherapeutic agents involves the oral ingestion of a slow release capsule containing adenine and orotate. The administration of a protein pump inhibitor decreases systemic absorption of orotate and the administration of allopurinol decreases the formation of 2,8-dihydroxy adenine from adenine. In an alternative embodiment, cationic liposomes contain purine/pyrimidine precursors. The cationic liposomes bind to the cells lining the mucosa of the intestinal tract and then the contents of the cationic liposome are then taken up in the interior of the cells to prevent the metabolism of the cancer treatment drug 5-FU into a toxic species.
Reference to Related Applications
This is a continuation-in-part patent application of application Ser. No. 12/381,474, filed Mar. 12, 2009, entitled "COMPOSITION AND METHOD FOR TREATMENT OF THE SIDE-EFFECTS ASSOCIATED WITH ADMINISTRATION OF CANCER CHEMOTHERAPEUTIC AGENTS", now abandoned, which claims one or more inventions which were disclosed in Provisional Application No. 61/069,031, filed Mar. 12, 2008, entitled "COMPOSITION AND METHOD FOR TREATMENT OF THE SIDE-EFFECTS ASSOCIATED WITH ADMINISTRATION OF CANCER CHEMOTHERAPEUTIC AGENTS". The benefit under 35 USC .sctn.119(e) of the United States provisional application is hereby claimed, and the aforementioned applications are hereby incorporated herein by reference.
Go Back for more representative patents.
Home || Intellectual Property || Patents || Trademarks || Copyrights
Brown & Michaels, PC
400 M & T Bank Building
118 North Tioga Street - The Commons
Ithaca, NY 14850
Phone: (607) 256-2000 · Fax: (607) 256-3628
© 2014 Brown & Michaels PC